Open original FDA record ↗Recall record
- FDA identifier
- Z-1286-2023
- Company in FDA record
- Randox Laboratories
- FDA classification date
- Sep 30, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range
Source facts
- Action
- Randox UK (manufacturer) extended Urgent Medical Device Removal letter to the US distributor via email on 2/1/23. The distributor contacted the customer via email on 2/6/23. Letter states reason for recall, health risk and action to take: " Discontinue use of and discard any of the above immediately. Provide Randox with photographic evidence of the destruction of the kits. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days. If you have any questions or concerns, please contact Randox Technical Services.
- Initiated
- 2023-02-01
- Root cause
- Under Investigation by firm
- Distribution
- PA, OH, WV
- Recall number
- Z-1286-2023
- Recall status
- Open, Classified
- CDRH record ID
- 198747
- FDA classified
- 2024-09-30
- Recall event number
- 91745